## **Core Concept**
Bradykinin is a peptide that plays a significant role in the body's inflammatory response and blood pressure regulation. It is a key component of the kallikrein-kinin system and acts on various receptors to exert its effects. The primary actions of bradykinin include vasodilation, increased vascular permeability, and smooth muscle contraction.

## **Why the Correct Answer is Right**
The correct answer, , indicates that bradykinin causes vasodilation. Bradykinin acts on endothelial cells to release **endothelium-derived relaxing factor (EDRF)**, which is primarily **nitric oxide (NO)**. NO then diffuses to the smooth muscle cells of blood vessels, causing them to relax and leading to vasodilation. This action contributes to the decrease in blood pressure and is a critical aspect of the inflammatory response, leading to increased blood flow to the affected area.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - Incorrect because while bradykinin does increase vascular permeability, the most direct and universally acknowledged effect from the given options is vasodilation.
* **Option B:** - Incorrect because bradykinin causes a decrease, not an increase, in blood pressure due to its vasodilatory effects.
* **Option C:** - Incorrect as this option is not provided, but based on the correct answer, we can infer that the other options do not accurately describe a primary effect of bradykinin.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **ACE inhibitors**, commonly used in the treatment of hypertension and heart failure, work by inhibiting the conversion of angiotensin I to angiotensin II. As a side effect, ACE inhibitors also prevent the breakdown of bradykinin, which can lead to increased levels of bradykinin. This increase in bradykinin is thought to contribute to the **cough** side effect experienced by some patients taking ACE inhibitors.

## **Correct Answer:** . Vasodilation